Immunofluorescent detection of hormone receptors in cutaneous melanocytic tumours
Open Access
- 1 May 1981
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 43 (5) , 644-653
- https://doi.org/10.1038/bjc.1981.95
Abstract
Immunofluorescent assessment of hormone receptors in melanocytic tumours is quite feasible without loss of diagnostic material, in contrast to the impracticability of quantitative biochemical assays. Using this method, oestrogen receptors were demonstrated in 4/6, and progesterone receptors in 3/5 patients with metastatic melanoma. Receptors were not found in 3 patients with primary cutaneous melanomas of the superficial spreading type. Progesterone receptors were present in the junctional component of a naevus from one healthy person.Keywords
This publication has 17 references indexed in Scilit:
- Hormones in breast cancer: Update 1978Metabolism, 1978
- Immunofluorescent detection of estrogen receptors in breast cancer.Comparison with dextran-coated charcoal and sucrose gradient assaysCancer, 1978
- CHARACTERIZATION AND ASSAY OF PROGESTERONE RECEPTOR IN HUMAN MAMMARY-CARCINOMA1977
- ŒSTROGEN RECEPTORS IN HUMAN MALIGNANT MELANOMAThe Lancet, 1976
- Adverse effect of pregnancy on melanoma. A reappraisalCancer, 1976
- MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptorsSteroids, 1975
- A simple method for the determination of oestrogen receptor concentrations in breast tumours and other tissuesClinica Chimica Acta; International Journal of Clinical Chemistry, 1975
- The Lysosome as a Mediator of Hormone ActionPublished by Elsevier ,1974
- Is Malignant Melanoma an Endocrine-Dependent Tumor?Oncology, 1973
- Solid-Phase Radioimmunoassay of Estradiol-17βJournal of Clinical Endocrinology & Metabolism, 1969